Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Social media and networks in pharmacovigilance: boon or bane?

Literature DB >> 21417499

Social media and networks in pharmacovigilance: boon or bane?

I Ralph Edwards, Marie Lindquist.

Abstract

Mesh：

Year: 2011 PMID： 21417499 DOI： 10.2165/11590720-000000000-00000

Source DB: PubMed Journal: Drug Saf ISSN： 0114-5916 Impact factor: 5.606

× No keyword cloud information.

2 in total

1. Using Facebook to increase spontaneous reporting of adverse drug reactions.

Authors: Marinela Z Knezevic; Ivana C Bivolarevic; Tanja S Peric; Slobodan M Jankovic
Journal: Drug Saf Date: 2011-04-01 Impact factor: 5.606

2. Motives for reporting adverse drug reactions by patient-reporters in the Netherlands.

Authors: Florence van Hunsel; Christine van der Welle; Anneke Passier; Eugène van Puijenbroek; Kees van Grootheest
Journal: Eur J Clin Pharmacol Date: 2010-07-24 Impact factor: 2.953

2 in total

20 in total

Review 1. Experiences with adverse drug reaction reporting by patients: an 11-country survey.

Authors: Florence van Hunsel; Linda Härmark; Shanthi Pal; Sten Olsson; Kees van Grootheest
Journal: Drug Saf Date: 2012-01-01 Impact factor: 5.606

2. Social Media Listening for Routine Post-Marketing Safety Surveillance.

Authors: Gregory E Powell; Harry A Seifert; Tjark Reblin; Phil J Burstein; James Blowers; J Alan Menius; Jeffery L Painter; Michele Thomas; Carrie E Pierce; Harold W Rodriguez; John S Brownstein; Clark C Freifeld; Heidi G Bell; Nabarun Dasgupta
Journal: Drug Saf Date: 2016-05 Impact factor: 5.606

Social media and networks in pharmacovigilance: boon or bane?

1. Using Facebook to increase spontaneous reporting of adverse drug reactions.

2. Motives for reporting adverse drug reactions by patient-reporters in the Netherlands.

Review 1. Experiences with adverse drug reaction reporting by patients: an 11-country survey.

2. Social Media Listening for Routine Post-Marketing Safety Surveillance.

3. Text mining for adverse drug events: the promise, challenges, and state of the art.

Review 4. Utilizing social media data for pharmacovigilance: A review.

5. Can social media benefit drug safety?

6. Fraudulent and substandard medicines: getting away with murder?

7. Portable automatic text classification for adverse drug reaction detection via multi-corpus training.

8. Pharmacovigilance for a revolving world: prospects of patient-generated data on the internet.

9. A framework for assessing the economic value of pharmacovigilance in low- and middle-income countries.

Review 10. Using social media in safety signal management: is it reliable?